Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. It specializes in development, production, process, and sale of ultraviolet absorbers, cholesterol phosphate binders, vitamin D derivatives, anti-inflammatory analgesic, and central nervous system drugs. The company's products include active pharmaceutical ingredients, contract research and custom synthesis, integrated application delivery controller services, and ultraviolet filters for sunscreens and cosmetics. Formosa Laboratories was founded by Cheng Yu Cheng on December 29, 1995 and is headquartered in Taoyuan, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company